Cite
HARVARD Citation
Le, Q. et al. (2019). Cost-effectiveness Analysis of Sequential Treatment of Abaloparatide Followed by Alendronate Versus Teriparatide Followed by Alendronate in Postmenopausal Women With Osteoporosis in the United States. Annals of pharmacotherapy. 53 (2), pp. 134-143. [Online].